Replies to post #1738 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

OK—thanks for the clarification about Kineret.

>this is all a big boondoggle motivated by my interest in understanding Merrimack's delay in reporting results. I am not assuming the worst like some.<

Nor am I given that:

1. GTC is projecting Q4 receipts from Merrimack for MM-093 clinical-trial supplies; and

2. GTC has increased (or is in the process of increasing) the size of the Merrimack goat herd.

Regards, Dew